NHS cancer gene database to allow families to check risk

A new national register is being developed to compile genetic risk information for cancer patients and those with a family history of the disease. Tens of thousands already undergo genetic testing annually, and those identified with a higher risk profile will be included in this centralized database.

A Proactive Approach to Cancer Care

The initiative, described as a 10-year plan to improve cancer prevention and treatment, represents a significant step toward personalized cancer care. According to NHS England’s national cancer director, this is “the first time any health care system has brought together all the information about all the genetic risk into a single place.”

How the Register Will Function

The register will consolidate existing genetic tests already offered to assess cancer susceptibility. This will allow healthcare practitioners to proactively “keep tabs on people” and offer targeted screening and, in some cases, preventative treatment as new options become available. The system is designed to be “incredibly confidential and secure.”

Did You Know? The NHS already maintains a similar database for Lynch syndrome, which has resulted in over 12,000 people being offered routine preventative screening.

While acknowledging that learning about increased cancer risk can be “very daunting,” Prof. Peter Johnson emphasized the potential for earlier detection and intervention. The goal is to identify the disease at its most treatable stages.

Personal Stories Highlight the Impact

The potential benefits of genetic testing and targeted treatment are illustrated by the experience of Charlie Grinstead, who was diagnosed with bowel cancer in 2020. His Lynch syndrome diagnosis led to access to immunotherapy after chemotherapy proved unsuccessful, ultimately proving to be “the key to my recovery.”

Expert Insight: Centralizing genetic risk data could streamline the process of identifying individuals who would benefit most from emerging preventative therapies and screening protocols, potentially leading to improved outcomes and a more efficient allocation of healthcare resources.

The NHS plans to use the register to monitor individuals and offer new tests and treatments as they are introduced. This suggests a dynamic system that will evolve alongside advancements in cancer research and clinical practice.

Frequently Asked Questions

What is the purpose of the new register?

The register is being built as part of a 10-year plan to improve cancer prevention and treatment by bringing together information about genetic risk into a single place.

Who will be included in the register?

Those known to have a higher risk profile, based on existing genetic testing, will be added to the new register.

What will happen once someone is on the register?

Individuals on the register will be given tailored information about lowering their cancer risk or detecting it early, and may be offered screening or preventative treatment.

How might a centralized genetic risk register influence the future of cancer screening and treatment?